LVIS Corporation launches AI platform that simplifies ambulatory review for effortless clinical workflows
LVIS Corporation has announced a major enhancement to its NeuroMatch platform with the release of full ambulatory EEG capability.
The AI-powered platform rapidly analyzes large data sets, automatically identifies and flags relevant neurological events, and filters out common artifacts such as muscle or eye movements all in a browser-based interface that requires no downloads, installations, or dedicated hardware.
This expanded capability will allow healthcare providers to launch, monitor, and interpret ambulatory EEG studies from any internet-connected device, at any time. Physicians can start a review in the hospital, continue from home, and finalize reports from their office, all without interrupting workflow or toggling between systems. Reports can be signed, summarized, and delivered within the same platform. Cloud-based infrastructure allows teams to collaborate across facilities without compromising quality or data consistency.
Designed with clinical efficiency in mind, NeuroMatch features seizure and spike trend visualizations, customizable report templates, daily summaries, integrated annotations, and secure digital signatures. These features are built to reflect and enhance the way neurologists already work.
